Introduction: Podocyte injury has been proven to be a major cause for poor renal outcomes after acute kidney injury (AKI). However, clinical trial data are still limited. This study aimed to explore the clinical correlations between podocyte injury and renal outcomes in hospitalized AKI patients. Method: This retrospective study analyzed data on 52 AKI patients who were histologically diagnosed with acute tubular necrosis or acute interstitial nephritis from six centers throughout China between January 2012 and June 2023. Patients were classified into two groups based on the degree of foot process fusion: ≤50% (mild podocyte injury group) and >50% (severe podocyte injury group). The outcomes were post-AKI new-onset proteinuria and incident CKD. Results: Among 52 AKI patients (14 male; median age, 49 [30, 56] years), 28 (53.8%) had mild podocyte injury; 24 (46.2%) had severe podocyte injury. After 12-month follow-up, 16 (57.1%) had post-AKI new-onset proteinuria, and 5 (17.9%) had post-AKI incident CKD in mild podocyte injury group. Twenty (83.3%) had post-AKI new-onset proteinuria, and 14 (58.3%) had post-AKI incident CKD in severe podocyte injury group. Patients with more severe foot process fusion exhibited significantly higher incidences of post-AKI new-onset proteinuria (83.3% vs. 57.1%, p = 0.041) and incident CKD (58.3% vs. 17.9%, p = 0.003) at 12 months following AKI. The degree of foot process fusion (95% CI 1.013∼3.88, p = 0.048) and proteinuria at 3 months (95% CI 1.309∼5.443, p = 0.015) were identified as independent risk factors for post-AKI new-onset proteinuria at 12 months. The degree of foot process fusion (95% CI 1.026∼14.196, p = 0.048), and the presence of partial renal pathological features, including tubular atrophy (95% CI 1.012∼5.958, p = 0.030), interstitial inflammation (95% CI 1.005∼6.846, p = 0.039), interstitial fibrosis (95% CI 1.110∼6.075, p = 0.043) were independent risk factors for post-AKI incident CKD at 12 months. Kaplan-Meier analysis shows severe podocyte injury group had worst renal survival, including post-AKI new-onset proteinuria (p = 0.0066) and incident CKD (p = 0.0455). Conclusion: The degree of podocyte injury is an independent risk factor for post-AKI new-onset proteinuria and incident CKD in patients, and patients with more severe podocyte injury exhibit a higher incidence of post-AKI new-onset proteinuria and incident CKD.

Podocyte injury has been proven to be a major cause for poor renal outcomes after acute kidney injury (AKI). However, data of clinical trials are still lacking. Hence, we made a retrospective study evaluating data on 52 AKI patients who underwent kidney biopsy from 6 centers throughout China between January 2012 and June 2023. In the present study, it was found that the degree of podocyte injury, as indicated by foot process fusion, is an independent risk factor for new-onset proteinuria and incident CKD in patients following AKI, and patients with more severe podocyte injury exhibited higher incidence of post-AKI new-onset proteinuria and incident CKD. These findings highlight the critical role of podocyte health in the prognosis of AKI patients and suggest that assessing podocyte injury may aid in identifying individuals at higher risk for adverse renal outcomes.

1.
Hoste
EAJ
,
Kellum
JA
,
Selby
NM
,
Zarbock
A
,
Palevsky
PM
,
Bagshaw
SM
, et al
.
Global epidemiology and outcomes of acute kidney injury
.
Nat Rev Nephrol
.
2018
;
14
(
10
):
607
25
.
2.
Noble
RA
,
Lucas
BJ
,
Selby
NM
.
Long-term outcomes in patients with acute kidney injury
.
Clin J Am Soc Nephrol
.
2020
;
15
(
3
):
423
9
.
3.
Hoste
EA
,
Bagshaw
SM
,
Bellomo
R
,
Cely
CM
,
Colman
R
,
Cruz
DN
, et al
.
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
.
Intensive Care Med
.
2015
;
41
(
8
):
1411
23
.
4.
Li
PK
,
Burdmann
EA
,
Mehta
R
;
World Kidney Day Steering Committee 2013
.
Acute kidney injury: global health alert
.
Transplantation
.
2013
;
95
(
5
):
653
7
.
5.
Sato
Y
,
Takahashi
M
,
Yanagita
M
.
Pathophysiology of AKI to CKD progression
.
Semin Nephrol
.
2020
;
40
(
2
):
206
15
.
6.
Heung
M
,
Steffick
DE
,
Zivin
K
,
Gillespie
BW
,
Banerjee
T
,
Hsu
CY
, et al
.
Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data
.
Am J Kidney Dis
.
2016
;
67
(
5
):
742
52
.
7.
See
EJ
,
Jayasinghe
K
,
Glassford
N
,
Bailey
M
,
Johnson
DW
,
Polkinghorne
KR
, et al
.
Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure
.
Kidney Int
.
2019
;
95
(
1
):
160
72
.
8.
Chen
Y
,
Lin
L
,
Tao
X
,
Song
Y
,
Cui
J
,
Wan
J
.
The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis
.
BMC Nephrol
.
2019
;
20
(
1
):
106
.
9.
Rayego-Mateos
S
,
Marquez-Expósito
L
,
Rodrigues-Diez
R
,
Sanz
AB
,
Guiteras
R
,
Doladé
N
, et al
.
Molecular mechanisms of kidney injury and repair
.
Int J Mol Sci
.
2022
;
23
(
3
):
1542
.
10.
Nagata
M
.
Podocyte injury and its consequences
.
Kidney Int
.
2016
;
89
(
6
):
1221
30
.
11.
Ma
S
,
Qiu
Y
,
Zhang
C
.
Cytoskeleton rearrangement in podocytopathies: an update
.
Int J Mol Sci
.
2024
;
25
(
1
):
647
.
12.
Kopp
JB
,
Anders
HJ
,
Susztak
K
,
Podestà
MA
,
Remuzzi
G
,
Hildebrandt
F
, et al
.
Podocytopathies
.
Nat Rev Dis Primers
.
2020
;
6
(
1
):
68
.
13.
Hu
X
,
Zhou
W
,
Wu
S
,
Wang
R
,
Luan
Z
,
Geng
X
, et al
.
Tacrolimus alleviates LPS-induced AKI by inhibiting TLR4/MyD88/NF-κB signalling in mice
.
J Cell Mol Med
.
2022
;
26
(
2
):
507
14
.
14.
Bhatraju
PK
,
Zelnick
LR
,
Chinchilli
VM
,
Moledina
DG
,
Coca
SG
,
Parikh
CR
, et al
.
Association between early recovery of kidney function after acute kidney injury and long-term clinical outcomes
.
JAMA Netw Open
.
2020
;
3
(
4
):
e202682
.
15.
Venkatachalam
MA
,
Weinberg
JM
,
Kriz
W
,
Bidani
AK
.
Failed tubule recovery, AKI-CKD transition, and kidney disease progression
.
J Am Soc Nephrol
.
2015
;
26
(
8
):
1765
76
.
16.
Oh
SW
,
Kim
S
,
Na
KY
,
Chae
DW
,
Kim
S
,
Jin
DC
, et al
.
Clinical implications of pathologic diagnosis and classification for diabetic nephropathy
.
Diabetes Res Clin Pract
.
2012
;
97
(
3
):
418
24
.
17.
Kim
H
,
Jo
SK
,
Ahn
SY
,
Kwon
YJ
,
Lee
H
,
Oh
J
, et al
.
Long-term renal outcome of biopsy-proven acute tubular necrosis and acute interstitial nephritis
.
J Korean Med Sci
.
2020
;
35
(
26
):
e206
.
18.
Deegens
JKJ
,
Dijkman
HB
,
Borm
GF
,
Steenbergen
EJ
,
van den Berg
JG
,
Weening
JJ
, et al
.
Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis
.
Kidney Int
.
2008
;
74
(
12
):
1568
76
.
19.
Stevens
PE
,
Levin
A
;
Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members
.
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline
.
Ann Intern Med
.
2013
;
158
(
11
):
825
30
.
20.
Parr
SK
,
Matheny
ME
,
Abdel-Kader
K
,
Greevy
RA
Jr
,
Bian
A
,
Fly
J
, et al
.
Acute kidney injury is a risk factor for subsequent proteinuria
.
Kidney Int
.
2018
;
93
(
2
):
460
9
.
21.
Siew
ED
,
Abdel-Kader
K
,
Perkins
AM
,
Greevy
RA
Jr
,
Parr
SK
,
Horner
J
, et al
.
Timing of recovery from moderate to severe AKI and the risk for future loss of kidney function
.
Am J Kidney Dis
.
2020
;
75
(
2
):
204
13
.
22.
Su
L
,
Li
Y
,
Chen
R
,
Zhang
X
,
Cao
Y
,
Luo
F
, et al
.
Epidemiology and outcomes of post-AKI proteinuria
.
Clin Kidney J
.
2023
;
16
(
11
):
2262
70
.
23.
MacLaughlin
HL
,
Pike
M
,
Selby
NM
,
Siew
E
,
Chinchilli
VM
,
Guide
A
, et al
.
Body mass index and chronic kidney disease outcomes after acute kidney injury: a prospective matched cohort study
.
BMC Nephrol
.
2021
;
22
(
1
):
200
.
24.
Li
PK
,
Burdmann
EA
,
Mehta
RL
;
World Kidney Day Steering Committee 2013
.
Acute kidney injury: global health alert
.
Transplantation
.
2013
;
95
(
5
):
653
7
.
25.
Muiru
AN
,
Hsu
JY
,
Zhang
X
,
Appel
LJ
,
Chen
J
,
Cohen
DL
, et al
.
Risk for chronic kidney disease progression after acute kidney injury: findings from the chronic renal insufficiency cohort study
.
Ann Intern Med
.
2023
;
176
(
7
):
961
8
.
26.
Amdur
RL
,
Chawla
LS
,
Amodeo
S
,
Kimmel
,
PL
,
Palant
,
CE
.
Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis
.
Kidney Int
.
2009
;
76
(
10
):
1089
97
,
27.
Ishani
A
,
Nelson
D
,
Clothier
B
,
Schult
T
,
Nugent
S
,
Greer
N
, et al
.
The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death
.
Arch Intern Med
.
2011
;
171
(
3
):
226
33
.
28.
Wang
Z
,
Zhang
C
.
From AKI to CKD: maladaptive repair and the underlying mechanisms
.
Int J Mol Sci
.
2022
;
23
(
18
):
10880
.
29.
Asanuma
K
,
Mundel
P
.
The role of podocytes in glomerular pathobiology
.
Clin Exp Nephrol
.
2003
;
7
(
4
):
255
9
.
30.
Peng
Y
,
Zhang
X
,
Wang
Y
,
Li
S
,
Wang
J
,
Liu
L
.
Overexpression of toll-like receptor 2 in glomerular endothelial cells and podocytes in septic acute kidney injury mouse model
.
Ren Fail
.
2015
;
37
(
4
):
694
8
.
31.
Chen
Y
,
Lin
L
,
Rao
S
,
Tao
X
,
Cui
J
,
Wan
J
.
Complement C3 mediates podocyte injury through TLR4/NFΚB-P65 signaling during ischemia-reperfusion acute kidney injury and post-injury fibrosis
.
Eur J Med Res
.
2023
;
28
(
1
):
135
.
32.
Horne
KL
,
Packington
R
,
Monaghan
J
,
Reilly
T
,
Selby
NM
.
Three-year outcomes after acute kidney injury: results of a prospective parallel group cohort study
.
BMJ Open
.
2017
;
7
(
3
):
e015316
.
33.
Malhotra
R
,
Siew
ED
.
Biomarkers for the early detection and prognosis of acute kidney injury
.
Clin J Am Soc Nephrol
.
2017
;
12
(
1
):
149
73
.
34.
Hsu
CY
,
Chinchilli
VM
,
Coca
S
,
Devarajan
P
,
Ghahramani
N
,
Go
AS
, et al
.
Post-acute kidney injury proteinuria and subsequent kidney disease progression: the assessment, serial evaluation, and subsequent sequelae in acute kidney injury (ASSESS-AKI) study
.
JAMA Intern Med
.
2020
;
180
(
3
):
402
10
.
You do not currently have access to this content.